Current Ratio of Acrivon Therapeutics, Inc. from 30 Jun 2023 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Acrivon Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2023 to 30 Sep 2025.
  • Acrivon Therapeutics, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 1018%, a 20% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Acrivon Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 1018% -247% -20% 30 Sep 2025
Q2 2025 1119% -206% -16% 30 Jun 2025
Q1 2025 1239% -157% -11% 31 Mar 2025
Q4 2024 1270% -292% -19% 31 Dec 2024
Q3 2024 1266% -677% -35% 30 Sep 2024
Q2 2024 1325% -581% -30% 30 Jun 2024
Q1 2024 1396% 31 Mar 2024
Q4 2023 1562% 31 Dec 2023
Q3 2023 1942% 30 Sep 2023
Q2 2023 1906% 30 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.